Implications in the POLO Study

Implications in the POLO Study

moasc

5 months
12 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Afsaneh Barzi, MD of Keck School of Medicine discusses the immediate implications in the POLO trial is mandatory germline testing for all patients with pancreatic cancer.

Up Next Autoplay
National Brain Tumor Society to Provide Funding for ONC201 Trial in EGFR-Independent High-Grade Gliomas
National Brain Tumor Society to Provide Funding for ONC201 Trial in EGFR-Independent High-Grade Gliomas
Category: Acute Lymphoblastic Leukemia
2 Views
alexvarney 20 hours
Supportive Care Video Series 2019 - Aromatase Inhibitor Induced Arthralgia (AI Induced Arthralgia)
Supportive Care Video Series 2019 - Aromatase Inhibitor Induced Arthralgia (AI Induced Arthralgia)
Category: Acute Lymphoblastic Leukemia
5 Views
cancergrace 3 weeks
Global Resource for Advancing Cancer Education Live Stream - Controversies in Managing NSCLC
Global Resource for Advancing Cancer Education Live Stream - Controversies in Managing NSCLC
Category: Acute Lymphoblastic Leukemia
5 Views
cancergrace 3 weeks
What is Immunotherapy with Dr. Narjust Duma (Spanish)
What is Immunotherapy with Dr. Narjust Duma (Spanish)
Category: Acute Lymphoblastic Leukemia
66 Views
cancergrace 3 weeks
Supportive Care 2019 - Androgen Deprivation Therapy (ADT) for Men with Prostate Cancer
Supportive Care 2019 - Androgen Deprivation Therapy (ADT) for Men with Prostate Cancer
Category: Acute Lymphoblastic Leukemia
9 Views
cancergrace 3 weeks
The Role of Immunotherapy in Metastatic Bladder Cancer
The Role of Immunotherapy in Metastatic Bladder Cancer
Category: Acute Lymphoblastic Leukemia
5 Views
cancergrace 3 weeks
What is Lung Cancer Screening (Spanish)
What is Lung Cancer Screening (Spanish)
Category: Acute Lymphoblastic Leukemia
3 Views
cancergrace 3 weeks
2019 Nobel Prize for Medicine Recipients recognized for Cancer Research  through study of von Hippel-Lindau (VHL) disease
2019 Nobel Prize for Medicine Recipients recognized for Cancer Research through study of von Hippel-Lindau (VHL) disease
Category: Acute Lymphoblastic Leukemia
6 Views
Cancer-News 1 month
INNATE PHARMA HIGHLIGHTS FDA-APPROVED LUMOXITI® AT ASH 2019
INNATE PHARMA HIGHLIGHTS FDA-APPROVED LUMOXITI® AT ASH 2019
Category: Acute Lymphoblastic Leukemia
25 Views
Cancer-News 1 month
Phase 1/2 AUGMENT-101 Trial @sloan_kettering
Phase 1/2 AUGMENT-101 Trial @sloan_kettering
Category: Acute Lymphoblastic Leukemia
14 Views
Memorial Sloan Kettering 2 months